A) The use of embryonic stem cells. B) The lack of potential applications. C) The uncontroversial ethical implications. D) The ease of obtaining stem cells from adults.
A) Funding from private corporations only. B) Speed of research progress above all else. C) Ignoring public opinions and concerns. D) Ethical guidelines and regulations.
A) To eliminate competition among research institutions. B) To address regulatory disparities and ensure ethical standards. C) To hinder progress in the field. D) To avoid sharing scientific breakthroughs.
A) Creating financial barriers to stem cell research. B) Promoting unregulated stem cell experimentation. C) Excluding patient advocates from the research process. D) Developing international policy guidance on stem cell research.
A) Repair, replace, and regenerate damaged cells or tissues. B) Create artificial intelligence using stem cells. C) Speed up the aging process in patients. D) Replace traditional medicine for all illnesses.
A) To prioritize scientific progress over societal implications. B) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. C) To ignore public opinions and concerns. D) To only focus on economic factors.
A) Serving as decision-makers for all stem cell research projects. B) Opposing all forms of medical research involving stem cells. C) Providing expertise on ethical implications and considerations. D) Advocating for unrestricted research with no ethical oversight.
A) Pluripotent cells are more versatile than totipotent cells. B) Pluripotent cells can only divide a limited number of times. C) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. D) There is no difference between the two types of stem cells. |